WPD Pharmaceuticals Statistics

Total Valuation

WPD Pharmaceuticals has a market cap or net worth of CAD 881,500. The enterprise value is 1.26 million.

Market Cap	881,500
Enterprise Value	1.26M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

WPD Pharmaceuticals has 4.64 million shares outstanding. The number of shares has increased by 0.57% in one year.

Current Share Class	n/a
Shares Outstanding	4.64M
Shares Change (YoY)	+0.57%
Shares Change (QoQ)	+1.65%
Owned by Insiders (%)	22.38%
Owned by Institutions (%)	n/a
Float	3.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-188.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio	0.10
Quick Ratio	0.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.93

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-71.58%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	115.14%
Revenue Per Employee	n/a
Profits Per Employee	-419
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.11% in the last 52 weeks. The beta is 0.75, so WPD Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-83.11%
50-Day Moving Average	0.16
200-Day Moving Average	0.33
Relative Strength Index (RSI)	54.32
Average Volume (20 Days)	307

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-290,036
Pretax Income	-6,706
Net Income	-6,706
EBITDA	-285,095
EBIT	-290,036
Earnings Per Share (EPS)	-0.00

Full Income Statement

Balance Sheet

The company has 9,339 in cash and 390,880 in debt, giving a net cash position of -381,541 or -0.08 per share.

Cash & Cash Equivalents	9,339
Total Debt	390,880
Net Cash	-381,541
Net Cash Per Share	-0.08
Equity (Book Value)	-622,289
Book Value Per Share	-0.13
Working Capital	-487,443

Full Balance Sheet

Cash Flow

Operating Cash Flow	-171,987
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

WPD Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.57%
Shareholder Yield	-0.57%
Earnings Yield	-0.76%
FCF Yield	n/a

Stock Splits

The last stock split was on December 30, 2024. It was a reverse split with a ratio of 0.04.

Last Split Date	Dec 30, 2024
Split Type	Reverse
Split Ratio	0.04

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a